Insiders · Profile

deBethizy J Donald

President and CEO at GYRE THERAPEUTICS. Filing since 11 Aug 2008. CIK 0001296027

Company
Date
Role
Action
Shares
Amount
Of holding
16 Dec 2009
President and CEO
Sold, plan not stated
237,930
$5.23M
100%
15 Dec 2009
President and CEO
Sold, plan not stated
15,391
$342.92K
34.7%
14 Dec 2009
President and CEO
Sold, plan not stated
2,600
$58.34K
5.5%
8 Sep 2009
President and CEO
Sold, plan not stated
851
$12.77K
1.8%
4 Sep 2009
President and CEO
Sold, plan not stated
11,149
$167.47K
19.2%
31 Aug 2009
President and CEO
Sold, plan not stated
9,400
$136.64K
16.7%
28 Aug 2009
President and CEO
Sold, plan not stated
600
$8.70K
1.3%
24 Aug 2009
President and CEO
Sold, plan not stated
2,400
$32.44K
4.9%
14 Aug 2009
President and CEO
Sold, plan not stated
4,600
$62.13K
8.9%
7 Aug 2009
President and CEO
Sold, plan not stated
5,700
$68.56K
10.8%
29 Jul 2009
President and CEO
Sold, plan not stated
5,700
$64.22K
10.8%
28 Jul 2009
President and CEO
Sold, plan not stated
2,600
$28.62K
5.3%
19 Aug 2008
President and CEO
Sold, plan not stated
1,700
$17.00K
1.8%
18 Aug 2008
President and CEO
Sold, plan not stated
900
$9.01K
1.0%
15 Aug 2008
President and CEO
Sold, plan not stated
100
$1.00K
0.1%
14 Aug 2008
President and CEO
Sold, plan not stated
1,473
$14.73K
1.5%
13 Aug 2008
President and CEO
Sold, plan not stated
2,324
$23.24K
2.4%
11 Aug 2008
President and CEO
Sold, plan not stated
100
$1.00K
0.1%
18 decisions on file.